Both have distinct yet complementary mechanisms that, when combined, may offer synergistic benefits
of the CY 2026 OPPS/ASC proposed rule, we also proposed that if more recent data are subsequently available (for example, a more recent estimate of the PPI for Pharmaceuticals for Human Use, Prescription), we would use such data, if appropriate, to determine the CY 2026 diagnostic radiopharmaceutical packaging threshold in the final rule
Sci Total Environ 653:274282
Case example : A patient receives drug test(s), presumptive, by direct optical observation or instrumented chemistry analyzers
BPC-157 is often chosen for narrower recovery discussions, while TB-500 is often chosen for broader ones